SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 223 filers reported holding SEATTLE GENETICS INC in Q3 2015. The put-call ratio across all filers is 1.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $325,000 | +72.9% | 1,911 | +17.5% | 0.01% | +75.0% |
Q1 2020 | $188,000 | -19.7% | 1,627 | -49.2% | 0.00% | -20.0% |
Q1 2019 | $234,000 | -53.3% | 3,201 | -50.8% | 0.01% | -54.5% |
Q3 2018 | $501,000 | +19.0% | 6,500 | -17.3% | 0.01% | +10.0% |
Q4 2017 | $421,000 | -1.6% | 7,861 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $428,000 | +5.2% | 7,861 | 0.0% | 0.01% | +11.1% |
Q2 2017 | $407,000 | -17.6% | 7,861 | 0.0% | 0.01% | -18.2% |
Q1 2017 | $494,000 | -37.5% | 7,861 | -55.3% | 0.01% | -42.1% |
Q4 2015 | $790,000 | -2.0% | 17,600 | -15.8% | 0.02% | -5.0% |
Q3 2015 | $806,000 | – | 20,900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |